Search

Your search keyword '"Dalban, Cecile"' showing total 24 results
Start Over Author "Dalban, Cecile"
24 results on '"Dalban, Cecile"'

1. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial

Author

Billon, Emilien, Dalban, Cécile, Oudard, Stephane, Chevreau, Christine, Laguerre, Brigitte, Barthélémy, Philippe, Borchiellini, Delphine, Geoffrois, Lionnel, Negrier, Sylvie, Joly, Florence, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Rolland, Frederic, Priou, Frank, Mahammedi, Hakim, Tantot, Florence, Escudier, Bernard, Chabaud, Sylvie, Albiges, Laurence, and Gravis, Gwenaelle

Published
2024
Full Text
View/download PDF

2. Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma

Author

Carril-Ajuria, Lucia, Lavaud, Pernelle, Dalban, Cecile, Negrier, Sylvie, Gravis, Gwénaëlle, Motzer, Robert J., Chevreau, Christine, Tannir, Nizar M., Oudard, Stéphane, McDermott, David F., Laguerre, Brigitte, Hammers, Hans J., Barthelemy, Philippe, Plimack, Elizabeth R., Borchiellini, Delphine, Gross-Goupil, Marine, Jiang, Ruiyun, Lee, Chung-Wei, de Silva, Heshani, Rini, Brian I., Escudier, Bernard, and Albigès, Laurence

Published
2024
Full Text
View/download PDF

3. Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer

Author

Cassier, Philippe A., Navaridas, Raul, Bellina, Melanie, Rama, Nicolas, Ducarouge, Benjamin, Hernandez-Vargas, Hector, Delord, Jean-Pierre, Lengrand, Justine, Paradisi, Andrea, Fattet, Laurent, Garin, Gwenaële, Gheit, Hanane, Dalban, Cecile, Pastushenko, Ievgenia, Neves, David, Jelin, Remy, Gadot, Nicolas, Braissand, Nicolas, Léon, Sophie, Degletagne, Cyril, Matias-Guiu, Xavier, Devouassoux-Shisheboran, Mojgan, Mery-Lamarche, Eliane, Allard, Justine, Zindy, Egor, Decaestecker, Christine, Salmon, Isabelle, Perol, David, Dolcet, Xavi, Ray-Coquard, Isabelle, Blanpain, Cédric, Bernet, Agnès, and Mehlen, Patrick

Published
2023
Full Text
View/download PDF

4. Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study

Author

Mourey, Loïc, Rainho, Larissa Tames, Dalban, Cécile, Carril-Ajuria, Lucía, Negrier, Sylvie, Chevreau, Christine, Gravis, Gwenaëlle, Thibault, Constance, Laguerre, Brigitte, Barthelemy, Philippe, Borchiellini, Delphine, Gross-Goupil, Marine, Geoffrois, Lionnel, Rolland, Frederic, Thiery-Vuillemin, Antoine, Tantot, Florence, Chaput, Nathalie, Naigeon, Marie, Teixeira, Marcus, Escudier, Bernard, Flippot, Ronan, and Albiges, Laurence

Published
2024
Full Text
View/download PDF

5. Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG—AFU 26 NIVOREN

Author

Guilhem-Ducléon, Guillemette, Dalban, Cécile, Negrier, Sylvie, Gravis, Gwenaelle, Laguerre, Brigitte, Chevreau, Christine, Oudard, Stéphane, Barthelemy, Philippe, Ladoire, Sylvain, Boughalem, Elouen, Borchiellini, Delphine, Linassier, Claude, Nenan, Soazig, Flippot, Ronan, Albiges, Laurence, and Goupil, Marine Gross

Published
2023
Full Text
View/download PDF

6. Comparison between exclusive (chemo)radiation and surgery or induction chemotherapy as first curative treatment for localized or locally advanced head and neck squamous cell carcinomas (L(A)-HNSCC): Sub-analysis of the EPOCKS study

Author

Gauduchon, Coauthor(s) Thibault, Dalban, Cécile, Philippe, Zrounba, Racadot, Séverine, Chabaud, Sylvie, Reyt, Emile, Poupart, Marc, Prades, Jean Michel, Burgy, Michael, Cellier, Dominique, Ceruse, Philippe, Leval, Jacques, Muller, Philippe, Manipoud, Patrick, Ray-Coquard, Isabelle, and Fayette, Jérôme

Published
2023
Full Text
View/download PDF

7. Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study

Author

Velev, Maud, Dalban, Cécile, Chevreau, Christine, Gravis, Gwenaelle, Negrier, Sylvie, Laguerre, Brigitte, Gross-Goupil, Marine, Ladoire, Sylvain, Borchiellini, Delphine, Geoffrois, Lionnel, Joly, Florence, Priou, Frank, Barthelemy, Philippe, Laramas, Mathieu, Narciso, Berangère, Thiery-Vuillemin, Antoine, Berdah, Jean-François, Ferrari, Victoria, Dominique Thomas, Quentin, Mione, Cécile, Curcio, Hubert, Oudard, Stephane, Tantot, Florence, Escudier, Bernard, Chabaud, Sylvie, Albiges, Laurence, and Thibault, Constance

Published
2023
Full Text
View/download PDF

8. Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Author

Rassy, Elie, Dalban, Cécile, Colomba, Emeline, Derosa, Lisa, Alves Costa Silva, Carolina, Negrier, Sylvie, Chevreau, Christine, Gravis, Gwenaelle, Oudard, Stephane, Laguerre, Brigitte, Barthelemy, Philippe, Goupil, Marine Gross, Geoffrois, Lionnel, Rolland, Frederic, Thiery-Vuillemin, Antoine, Joly, Florence, Ladoire, Sylvain, Tantot, Florence, Escudier, Bernard, and Albiges, Laurence

Published
2022
Full Text
View/download PDF

9. 849: Relapse Risk stratification in pediatric ependymoma patients using clinical data and radiomics

Author

Tensaouti, Fatima, Blanchard, Nhi, Morisseau, Mathilde, Bolle, Stéphanie, Escande, Alexandre, Muracciole, Xavier, Alapetite, Claire, Claude, Line, Leseur, Julie, Doyen, Jérôme, Noël, Georges, Supiot, Stéphane, Bernier-Chastagner, Valérie, Welmant, Julien, Hatt, Mathieu, Bengoufa, Soumia, Figarella-Branger, Dominique, Varlet, Pascale, Uro-Coste, Emmanuelle, Gautier, Julien, Dalban, Cécile, Leblond, Pierre, and Laprie, Anne

Published
2024
Full Text
View/download PDF

12. Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma

Author

Maréchal, Raphaël, Bachet, Jean–Baptiste, Mackey, John R., Dalban, Cécile, Demetter, Pieter, Graham, Kathryn, Couvelard, Anne, Svrcek, Magali, Bardier–Dupas, Armelle, Hammel, Pascal, Sauvanet, Alain, Louvet, Christophe, Paye, François, Rougier, Philippe, Penna, Christophe, André, Thierry, Dumontet, Charles, Cass, Carol E., Jordheim, Lars Petter, Matera, Eva–Laure, Closset, Jean, Salmon, Isabelle, Devière, Jacques, Emile, Jean–François, and Van Laethem, Jean–Luc

Published
2012
Full Text
View/download PDF

13. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases

Author

Paganin, Fabrice, Bourdin, Arnaud, Dalban, Cecile, Courtin, Jean-Paul, Poubeau, Patrice, Borgherini, Gianandrea, Michault, Alain, Sally, Jean-Claude, Tixier, Francois, Genin, Robert, and Arvin-Berod, Claude

Subjects
Leptospirosis -- Complications and side effects -- Research -- Risk factors, Pulmonary manifestations of general diseases -- Research -- Risk factors -- Complications and side effects, Health care industry
Abstract

Objective: Analysis of risk factors associated with severity in patients with confirmed leptospirosis. Design and setting: Retrospective study in 147 leptospirosis-confirmed patients at two tertiary non-teaching hospital in Reunion Island. Patients: 138 men and 9 women, aged 36 ± 14 years, 80 in the ICU and 67 in medical wards. Measurements and results: We collected demographic, clinical, biological, and radiographic data and performed univariate and multivariate analysis to examine risk factors associated with admission in ICU and mortality. Pulmonary forms were more frequent (85%) than in previous reports, with 85 cases (65.3%) on abnormal chest radiography. Among the 38 patients who underwent bronchoalveolar lavage at admission 31 (81.5%) had alveolar hemorrhage. Independent factors related to ICU admission were: age over 46 years (OR 3.02), creatinine higher than 200 µmol/l (6.69), shock (13.87), and acute respiratory failure (20.69). Mortality was 12.9%. The only factor independently related to mortality was need for mechanical ventilation (OR 20.94). Icterohemorrhagiae serogroup was found in 62 cases (42.8%) but was not related to death. Conclusions: Pulmonary involvement is a major feature in leptospirosis disease but is not associated with poor outcome. Identification of clinical and laboratory findings on admission may help to better characterize severe cases. Keywords Leptospirosis * Pulmonary manifestations * Risk factor * Mortality * Intensive care * Alveolar hemorrhage, Introduction Leptospirosis is a zoonosis caused by the genus leptospira interrogans and has a worldwide distribution. Although leptospirosis was initially considered an occupational disease, reports of cases have been increasing [...]

Published
2007
Full Text
View/download PDF

16. BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for Chemosensitive Relapses in Patients with Follicular Lymphoma: A Prospective Multicenter Phase II Study from Lymphoma Study Association (LYSA) Centers

Author

Ghesquieres, Herv, primary, Dalban, Cecile, additional, Nicolas-Virelizier, Emmanuelle, additional, Jardin, Fabrice, additional, Le Bras, Fabien, additional, Le Gouill, Steven, additional, Casasnovas, Rene-Olivier, additional, Vizoso, Seraphine, additional, Hernandez, Caroline, additional, Metzger, Severine, additional, Perol, David, additional, and Cartron, Guillaume, additional

Published
2018
Full Text
View/download PDF

17. Impact of bevacizumab added to temozolomide-chemoradiation on time to health-related quality of life deterioration in unresectable glioblastoma: Results of a phase II randomized clinical trial.

Author

Bonnetain, Franck, primary, Dabakuyo, Tienhan Sandrine, additional, Pozet, Astrid, additional, Feuvret, Loic, additional, Taillandier, Luc, additional, Frappaz, Didier, additional, Taillia, Herve, additional, Schott, Roland, additional, Honnorat, Jerôme, additional, Fabbro, Michel, additional, Tennevet, Isabelle, additional, Ghiringhelli, Francois, additional, Campello, Chantal, additional, Castera, Daniel, additional, Frenay, Marc, additional, Dalban, Cecile, additional, Skrzypski, Jeremy, additional, Chinot, Olivier L., additional, Chauffert, Bruno, additional, and Anota, Amelie, additional

Published
2015
Full Text
View/download PDF

19. Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial.

Author

Mariette, Christophe, primary, Meunier, Bernard, additional, Pezet, Denis, additional, Dalban, Cecile, additional, Collet, Denis, additional, Thomas, Pascal-Alexandre, additional, Brigand, Cecile, additional, Perniceni, Thierry, additional, Carrere, Nicolas, additional, Bonnetain, Franck, additional, and Piessen, Guillaume, additional

Published
2015
Full Text
View/download PDF

20. Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: A pooled analysis of two randomised trials

Author

Ladoire, Sylvain, primary, Dalban, Cecile, additional, Roché, Henri, additional, Spielmann, Marc, additional, Fumoleau, Pierre, additional, Levy, Christelle, additional, Martin, Anne Laure, additional, Ecarnot, Fiona, additional, Bonnetain, Frank, additional, and Ghiringhelli, François, additional

Published
2014
Full Text
View/download PDF

21. Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?

Author

Dewas-Vautravers, Claire, primary, Maingon, Philippe, additional, Dalban, Cecile, additional, Petitfils, Aurelie, additional, Peignaux-Casasnovas, Karine, additional, Truc, Gilles, additional, Martin, Etienne, additional, Khoury, Cedric, additional, Dewas, Sylvain, additional, and Crehange, Gilles, additional

Published
2013
Full Text
View/download PDF

24. Impact of Insertions in the HIV-1 P6 Ptapp Region on the Virological Response to Amprenavir

Author

Lastere, Stephane, Dalban, Cecile, Collin, Gilles, Descamps, Diane, Girard, Pierre-Marie, Clavel, Francois, Costagliola, Dominique, Brun-Vezinet, Francoise, Brun-Vezinet, F, Clavel, F, Costagliola, D, Dalban, C, Girard, PM, Matheron, S, Meynard, JL, Morand-Joubert, L, Peytavin, G, Vray, M, Beguinot, I, Waldner, A, Beumont, M, Semaille, C, Bentata, M, Berlureau, P, Gérard, L, Molina, JM, Hor, R, Bayol-Honnet, G, Lascoux-Combe, C, Drobacheff, C, Hoen, B, Dupon, M, Lacut, JY, Goujard, C, Rousseau, C, Vincent, V, Diemer, M, Lepeu, G, Zerazhi, H, de Truchis, P, Berthé, H, Jeantils, V, Tazi, C Taleb, Vittecoq, D, Escaut, L, Dupont, B, Nait-Ighil, L, Rozenbaum, W, Nguyen, T Huyen, Boué, F, Galanaud, P, Kazatchkine, M, Piketty, C, Bernasconi, C, Salmon-Ceron, D, Michon, C, Chandemerle, C, Lascaux, AS, Magnier, JD, Schneider, L, Ait-Mohand, H, Simon, A, Herson, S, Bollens, D, Picard, O, Tangre, P, Bonarek, M, Morlat, P, Trépo, C, Cotte, L, Gastaut, JA, Poizot-Martin, I, Moran, G, Masson, S, Bennai, Y, Belarbi, L, Prevot, MH, Fournier, I, Reynes, J, Baillat, V, Raffi, F, Esnault, JL, Ceppi, C, Cassuto, JP, Arvieux, C, Chapplain, JM, Rey, D, Krantz, V, Besnier, JM, Bastides, F, Obadia, M, Aquilina, C, Bazin, C, Verdon, R, Piroth, L, Grappin, M, Sissoko, D, Valette, M, May, T, Burty, C, Debab, Y, Caron, F, Elharrar, B, Launay, O, Winter, C, Chapuis, L, Auperin, I, and Gilquin, J

Abstract

We evaluated the impact of genetic changes within p6Gaggene on the virological response (VR, mean decrease in plasma viral load at week 12) to unboosted amprenavir (APV). Gag-protease fragments, including gag p2, p7, p1, p6 regions and whole protease (PR) were sequenced from baseline plasma specimens of 84 highly pre-treated but APV-naive patients included in the NARVAL (ANRS 088) trial. The correlation between baseline p6Gagpolymorphism, PR mutations, baseline characteristics and VR to APV was analysed in univariate analysis. Insertions (P459Ins) within p6 protein, leading to partial or complete duplication of the PTAPP motif, were significantly associated with a decreased VR (P459Ins versus wild-type; –0.3 ±0.8 vs –1.1 ±1.2 log copies/ml, P=0.007) and were more frequent when the V82A/F/T/S PR mutation was present (P=0.020). In multivariate analysis, after adjustment on the predictive factors of the VR in the NARVAL trial and on the PR mutations linked with response, there was a strong trend to an association (P=0.058) between the presence of P459Ins and an altered VR. In conclusion, these results suggest that insertions in the p6 region of HIV-1 gag gene may affect the VR, in highly pre-treated patients receiving an unboosted APV-containing regimen.

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results